Tricker A R, Mostafa M H, Spiegelhalder B, Preussmann R
Institute of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg, FRG.
Carcinogenesis. 1989 Mar;10(3):547-52. doi: 10.1093/carcin/10.3.547.
Saliva and 24-h urine samples were collected from male Schistosomiasis (bilharzia) patients with S. haematobium infection and possible concurrent S. mansoni infection without diagnosed bladder cancer (n = 27), bilharzia patients with diagnosed bladder cancer (n = 23) as well as a comparative control group (n = 27) of healthy Egyptian volunteers with no current bilharzia infection and/or bacterial urinary tract infections from the Nile Delta area of Egypt. Saliva samples were analysed for the presence of nitrate and nitrite; urine samples were analysed for the presence of nitrate, nitrite, volatile and non-volatile N-nitroso compounds. Bilharzia patients prior to, and after, diagnosed bladder cancer regularly excreted free nitrite as well as volatile nitrosamines (N-nitrosodimethylamine, N-nitrosodiethylamine, N-nitrosopiperidine and N-nitrosopyrrolidine) in addition to which elevated concentrations of non-volatile N-nitrosamino acids (N-nitrosoproline, N-nitrososarcosine, N-nitrosothiazolidine-4-carboxylic acid and its 2-methyl derivative) were also present. Total urinary excretion of volatile N-nitroso compounds (0.32 +/- 0.64 micrograms/day; mean +/- SD) and non-volatile N-nitroso compounds (31.20 +/- 22.07 micrograms/day) was observed in the Egyptian control group. Significantly higher concentrations were found in bilharzia patients: 3.47 +/- 6.42 (P less than 0.05) and 62.91 +/- 21.96 (P less than 0.05); as well as in bilharzia patients with diagnosed bladder cancer: 1.71 +/- 1.96 (P less than 0.02) and 44.94 +/- 7.31 respectively. Free nitrite was found in the urine of two volunteers in the Egyptian control group (1.7 and 3.0 micrograms/day), urinary nitrite was significantly increased in bilharzia patients (5.18 +/- 9.11 micrograms/day, P less than 0.02) and in bladder cancer patients (1.75 +/- 2.81 micrograms/day, P less than 0.05). Nitrate concentrations were elevated from 139.3 +/- 82.2 in the control group to 143.6 +/- 136.3 and 175 +/- 190 in the bilharzia and bladder cancer groups respectively. These results indicate that significant in vivo formation of nitrite and volatile N-nitroso compounds occurs in the urinary bladder of bilharzia patients and this may be an oetiological factor in the induction of bilharzial bladder cancer associated with S. haematobium infection.
收集了来自感染埃及血吸虫且可能同时感染曼氏血吸虫但未诊断出膀胱癌的男性血吸虫病(裂体吸虫病)患者(n = 27)、已诊断出膀胱癌的血吸虫病患者(n = 23)以及来自埃及尼罗河三角洲地区、目前无血吸虫感染和/或细菌性尿路感染的健康埃及志愿者组成的对照群体(n = 27)的唾液和24小时尿液样本。分析唾液样本中硝酸盐和亚硝酸盐的存在情况;分析尿液样本中硝酸盐、亚硝酸盐、挥发性和非挥发性N-亚硝基化合物的存在情况。已诊断出膀胱癌之前和之后的血吸虫病患者除了定期排泄游离亚硝酸盐以及挥发性亚硝胺(N-亚硝基二甲胺、N-亚硝基二乙胺、N-亚硝基哌啶和N-亚硝基吡咯烷)外,还存在非挥发性N-亚硝基氨基酸(N-亚硝基脯氨酸、N-亚硝基肌氨酸、N-亚硝基噻唑烷-4-羧酸及其2-甲基衍生物)浓度升高的情况。埃及对照组中挥发性N-亚硝基化合物的总尿排泄量为(0.32±0.64微克/天;平均值±标准差),非挥发性N-亚硝基化合物为(31.20±22.07微克/天)。在血吸虫病患者中发现浓度显著更高:分别为3.47±6.42(P<0.05)和62.91±21.96(P<0.05);在已诊断出膀胱癌的血吸虫病患者中分别为1.71±1.96(P<0.02)和44.94±7.31。在埃及对照组的两名志愿者尿液中发现了游离亚硝酸盐(1.7和3.0微克/天),血吸虫病患者尿液中的亚硝酸盐显著增加(5.18±9.11微克/天,P<0.02),膀胱癌患者中也增加(1.75±2.81微克/天,P<0.05)。硝酸盐浓度从对照组的139.3±82.2分别升高到血吸虫病组的143.6±136.3和膀胱癌组的175±190。这些结果表明,血吸虫病患者膀胱中在体内显著形成亚硝酸盐和挥发性N-亚硝基化合物,这可能是与埃及血吸虫感染相关的血吸虫性膀胱癌诱发的一个病因学因素。